# GE HealthCare Technologies Inc. (GEHC) fundamentals

Data as of 2026-11-04. NASDAQ, United States. Sector: Healthcare / Medical Devices & Supplies. Price $80.66, market value $36.5 billion.

## Valuation
- **P/E (trailing): 17.1×** (5-yr avg 18.8×, 3-yr avg 20.5×). GE HealthCare Technologies Inc. trades at 17.1× trailing earnings, close to its own five-year average of 18.8×. The Healthcare median in the September 2026 study was 28.5×. Forward P/E is 14.7×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 3.03**. A PEG of 3.03 means the P/E is high relative to expected earnings growth; the price already assumes a lot.
- **Price / sales: 1.7×**. Each dollar of revenue is priced at 1.7×.
- **Price / book: 3.1×**. The shares trade at 3.1× book value; book value is a meaningful part of the valuation.
- **Free-cash-flow yield: 5.2%** (5-yr avg 5.0%). Free cash flow equals 5.2% of the market value, in line with its five-year average of 5.0%. Above 5% is generally attractive.
- **Earnings yield: 5.9%**. The inverse of the P/E: 5.9% of the price is earned each year.

## Profitability
- **Gross margin: 39.9%**. GE HealthCare Technologies Inc. keeps 39.9% of revenue after the direct cost of what it sells.
- **Operating margin: 13.3%**. 13.3% of revenue is left after running the business.
- **Net margin: 10.1%**. 10.1% of each dollar of sales reaches the bottom line.
- **Return on equity: 20.1%**. 20.1% on shareholders' equity is excellent if it is not driven by leverage; sustained above 20% usually signals a competitive advantage.
- **Return on invested capital: 14.4%**. Return on all capital, debt included, is 14.4%.
- **Return on assets: 5.8%**. Each dollar of assets produces 5.8% of profit.

## Growth
- **Revenue growth (1 yr): 4.8%** (3-yr 4.0%/yr). Revenue grew 4.8% over the last year.
- **EPS growth (1 yr): 4.8%** (3-yr 2.5%/yr). Earnings per share rose 4.8%, roughly in step with revenue.
- **Free-cash-flow growth (3 yr): -6.2%/yr**. Free cash flow has compounded at -6.2% a year over three years, lagging earnings: check whether profits are turning into cash.

## Financial health
- **Debt to equity: 0.96**. Debt is 0.96 times equity, moderate leverage.
- **Current ratio: 1.37** (quick 1.37). Current assets cover the next year's liabilities 1.37 times.
- **Altman Z-score: 2.14**. A Z-score of 2.14 is in the grey zone; not distressed, not clearly safe.
- **Piotroski F-score: 4/9**. 4 of 9 checks pass: mixed.

## Dividends
- **Dividend yield: 0.20%** ($0.14 per share, trailing). GE HealthCare Technologies Inc. yields 0.20%, a modest yield more typical of a growth-oriented payer.
- **Payout ratio: 3%** (3% of free cash flow). 3% of earnings goes out as dividends, leaving room to keep raising it.
- **Consecutive years of increases: 3**. 3 straight years of increases.

## Analyst view
- **Analyst consensus: buy** (20 analysts). 20 analysts cover GE HealthCare Technologies Inc.; the consensus is buy, with an average price target of $87.50 (+8% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 6.3%** (YTD -2.9%, 3-mo 14.1%). The shares are up 6.3% over twelve months including dividends.
- **From 52-week high: -10.1%** (37.3% above the low). Trading 10% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 79**. An RSI of 79 is in overbought territory; short-term pullbacks are common from here.
- **Beta (1 yr): 0.74** (volatility 35%). Beta of 0.74 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=GEHC · Page: https://foliofundamentals.com/stocks/gehc

Not investment advice.